谷歌浏览器插件
订阅小程序
在清言上使用

Abstract CT249: Results from KEYMAKER-U01 Substudy 3: a Phase 2 Umbrella Study of Pembrolizumab Plus Investigational Agents in Patients with Non-Small-cell Lung Cancer (NSCLC) Previously Treated with Anti-Pd-(l)1 Therapy

Cancer Research(2024)

引用 0|浏览29
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要